2025 HCPCS Code J0751
Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
TAGS: emtricitabine 200mg alafenamide prophylaxis treatment approved tenofovir| Short Description | Hiv prep, ftc/taf 200/25mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 02, 2024 |
| HCPCS Action Effective Date | January 02, 2024 |
| HCPCS Pricing Indicator Code | 57 - Other carrier priced |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J0485 - Belatacept injection
- J0490 - Belimumab injection
- J0491 - Inj anifrolumab-fnia 1mg
- J0500 - Dicyclomine injection
- J0515 - Inj benztropine mesylate
- J0517 - Inj., benralizumab, 1 mg
- J0520 - Bethanechol chloride inject
- J0558 - Peng benzathine/procaine inj
- J0561 - Penicillin g benzathine inj
- J0565 - Inj, bezlotoxumab, 10 mg
- J0567 - Inj., cerliponase alfa 1 mg
- J0570 - Buprenorphine implant 74.2mg
- J0571 - Buprenorphine oral 1mg
- J0572 - Bupren/nal up to 3mg bupreno
- J0573 - Bupren/nal 3.1 to 6mg bupren
- J0574 - Bupren/nal 6.1 to 10mg bupre
- J0575 - Bupren/nal over 10mg bupreno
- J0576 - Inj buprenorph (brixadi) 1mg
- J0577 - Inj, brixadi, 7 days or less
- J0578 - Inj brixadi, more than 7 day